Indian Americans take priorities to Capitol Hill

IANS | June 23, 2026 6:27 PM

Washington, June 23 (IANS) Nearly 200 Indian American delegates from 25 states are set to meet lawmakers and Congressional staff across the Capitol Hill on Tuesday as part of a major advocacy effort focused on strengthening the US-India partnership, advancing immigration reform and bolstering Indo-Pacific security.

China fudges trade data to take IMF for a ride: Report

IANS | June 23, 2026 6:16 PM

New Delhi, June 23 (IANS) China has manipulated its trade data to show that its current account surplus as a share of GDP is smaller that of Europe and managed to get this data accepted by the IMF, according to a report published by Council on Foreign Relations (CFR).

VOC Port becomes a model for green maritime growth: Sarbananda Sonowal

IANS | June 23, 2026 6:11 PM

New Delhi, June 23 (IANS) The VO Chidambaranar Port Authority (VOCPA) has emerged as a model for sustainable maritime development in India, citing the port's significant progress in decarbonisation, renewable energy adoption and green infrastructure development, Union Minister of Ports, Shipping and Waterways (MoPSW), Sarbananda Sonowal, said on Tuesday.

India needs quantum jump into manufacturing high-value pharma products: Economists

IANS | June 23, 2026 6:06 PM

New Delhi, June 23 (IANS) India, which is one of the world’s largest suppliers of generic medicines and a major provider of vaccines and essential drugs, needs to make a quantum jump into manufacturing high-value pharmaceuticals and Active Pharmaceutical Ingredients (API), and there has to be strong Production Linked Incentive (PLI) schemes to achieve this, economists said on Tuesday.

India needs to strengthen its position as global pharmaceutical and innovation hub: NITI Aayog

IANS | June 23, 2026 5:32 PM

New Delhi, June 23 (IANS) While India remains one of the world’s largest suppliers of generic medicines and a major provider of vaccines and essential drugs, its global export share in pharmaceuticals and Active Pharmaceutical Ingredients (API) remains modest at 2.8 per cent, indicating scope for expansion amid rising global demand for medicines, biologics, and speciality therapeutics, a NITI Aayog report said on Tuesday.